"Corporate Governance and Firm-Level Competitive Behavior: Testing ""Capability"" and ""Motivation"" Effects in the United States Pharmaceutical Industry"

To test the hypotheses developed in accordance with the overall theoretical framework, I statistically investigate thirty-seven companies in the U.S. pharmaceutical industry over a three-year time period (1999-2001). The empirical results indicate that the board of directors has practically important resource provision roles. Adding more directors (especially independent outsiders) to the board and separating CEO and chairperson generally enhance a firm's capability for engaging in more assertive and diverse actions. In addition, moderating or motivational effects of the board also exist. Having more directors (especially independent outsiders) and assigning different individuals respectively as the CEO and the chairperson of the board are more effective in preventing shirking and encouraging managers to engage actively in more aggressive competitive actions. The empirical results also suggest that firm capability defines the scale and scope of firm-level competitive activity.

Name thesis:degree_name

Ph.D.

Level thesis:degree_level

Dissertation

Discipline thesis:degree_discipline

Business Administration

Grantor

University of Illinois at Urbana-Champaign

Year dc:date

2015

Author dc:creator

• He, Jinyu

Contributors dc:contributor

• Mahoney, Joseph T.

• Business Administration, Management

Language dc:language

eng

Identifier

(MiAaPQ)AAI3199015

OAI identifier oai:identifier

oai:www.ideals.illinois.edu:2142/84543